Investigating how small RNA affects genetically modified mosquitoes
Official title: Small RNA interactions with transgenes in genetically modified mosquito lines
Funded at University of North Texas · NIH-10654368 · Data updated 2026-11-12
This study is looking at how tiny RNA molecules in genetically modified mosquitoes might affect the genes that help control mosquito populations and fight diseases, with the goal of finding better ways to manage diseases spread by these insects.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of North Texas NIH-funded |
| Lab location | 1 site (Denton, United States) |
| Project start | July 1, 2023 |
| Project end | June 30, 2026 |
| Funding year | 2023 |
| Award (this year) | $466,440 |
| NIH project number | 1R15AI171800-01A1 |
| Project ID | NIH-10654368 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals living in regions affected by vector-borne diseases transmitted by mosquitoes.
✕Less likely to help
Patients who do not live in areas impacted by mosquito-borne diseases may not receive direct benefits from this research.
What this research studies
This research focuses on understanding how small RNA molecules interact with transgenes in genetically modified mosquitoes, specifically Aedes aegypti and Anopheles stephensi. By analyzing the activity of these small RNAs, the study aims to determine how they may regulate or inhibit the effectiveness of transgenes designed to control mosquito populations or block viruses. The researchers will use advanced sequencing techniques to identify small RNA activity and create a bioinformatics resource to help other scientists design more effective genetic constructs. This work could lead to improved strategies for controlling vector-borne diseases.
Why it matters
Potential benefit: If successful, this research could enhance the effectiveness of genetically modified mosquitoes in controlling diseases like malaria and dengue fever.
How similar studies have gone: Previous research has shown promise in using genetically modified organisms for disease control, indicating that this approach could yield significant advancements.
Where this research is happening
-
University of North Texas
Denton, United States Active
Researchers
- Principal investigator: Macias, Vanessa — University of North Texas
- Study coordinator: Macias, Vanessa
Related research
Other NIH-funded projects on the same topics.
-
Cataracts and Work Exposures in Denmark
A large Danish study will look at whether job-related exposures, both chemical and non-chemical, are linked to developing cataracts.
-
New approach to find noninvasive brain networks that predict epilepsy after brain injury
A study aims to identify noninvasive brain biomarkers that can forecast epileptogenesis after brain injury by linking MRI network patterns with EEG signals.
-
Off-the-shelf ADC-NK cell therapy platform for cancer and immune diseases
A universal, ready-to-use natural killer cell therapy armed with antibody-drug conjugates is being developed to target cancers and other diseases.
-
New and better ways to measure kids' exposure to air pollution and traffic
This project looks at how traffic-related air pollution and green space around homes may affect cancer risk in children and uses advanced exposure measurements to better understand these links.
-
Can a single model work for high-resolution 3D genome structure using generalizable methods
A grantfunds researchers to create high-resolution 3D genome models that can work across different cell types using advanced algorithms and machine learning.
-
How tissue stiffness and stretching affect nanoparticle delivery in cancer and other diseases
This grant studies how the physical properties of tissues, like stiffness and stretch, influence how nanoparticles are taken up by cancer-related cells to improve future therapies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.